Achieve Life Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 8731 http://achievelifesciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences Inc

ACHV: New Skipper at the Helm - Sep 4th, 2024 10:23 am
Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors - Aug 26th, 2024 8:30 pm
ACHV: ORCA OL Enrolling at Rapid Pace - Aug 19th, 2024 9:57 am
Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update - Aug 13th, 2024 8:01 pm
Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence - Jul 31st, 2024 12:00 pm
Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank - Jul 29th, 2024 12:00 pm
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 - Jul 25th, 2024 12:00 pm
Milestone Pharmaceuticals Refreshes Board of Directors - Jul 15th, 2024 12:00 pm
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 - Jul 9th, 2024 12:00 pm
With 64% ownership of the shares, Achieve Life Sciences, Inc. (NASDAQ:ACHV) is heavily dominated by institutional owners - Jul 5th, 2024 12:44 pm
Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes - Jul 1st, 2024 12:00 pm
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes - May 29th, 2024 12:00 pm
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting - May 17th, 2024 12:00 pm
ACHV: First Quarter Results - May 13th, 2024 9:21 am
Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results - May 10th, 2024 7:47 pm
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript - May 10th, 2024 4:41 pm
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update - May 9th, 2024 8:01 pm
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine - May 6th, 2024 3:16 pm
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV - Apr 29th, 2024 1:00 pm
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 - Apr 25th, 2024 12:00 pm